Dexamethasone suppression test and the response to antidepressant depending on their central monoaminergic action in major depression.
After 1 mg DST, 25 major depressive patients (DSM-III) received at random either a specific inhibitor of noradrenaline reuptake (Maprotiline) or an inhibitor of serotonin reuptake (Indalpine or Citalopram). After at least 3 weeks of treatment, no difference was found in treatment response between suppressors and non suppressors. This study is unable to confirm the usefulness of the DST in selection of treatment according to its central activity on serotonin or noradrenaline-reuptake.
Benkelfat
C
C
Poirier
M F
MF
Léouffre
P
P
Gay
C
C
Löo
H
H
D000328:Adult; D000368:Aged; D000873:Anthracenes / Q000627:therapeutic use*; D015283:Citalopram; D003866:Depressive Disorder / Q000175:diagnosis / Q000188:drug therapy*; D003907:Dexamethasone; D005260:Female; D006801:Humans; D008297:Male; D008376:Maprotiline / Q000494:pharmacology / Q000627:therapeutic use*; D008875:Middle Aged; D010880:Piperidines / Q000494:pharmacology / Q000627:therapeutic use*; D011437:Propylamines / Q000494:pharmacology / Q000627:therapeutic use*
D000873:Anthracenes; D010880:Piperidines; D011437:Propylamines; D015283:Citalopram; D008376:Maprotiline; D003907:Dexamethasone; C018181:indalpine